Home
COGT
COGT News

Latest Cogent Biosciences Inc. (COGT) News on July 13, 2025

Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing

GlobeNewswire

a month ago

Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing

Will Tesla have to play catch up to Waymo's robotaxis?

Yahoo Finance Video

a month ago

Will Tesla have to play catch up to Waymo's robotaxis?

Why Scott Bessent wants to make it easier for banks to own Treasurys

Yahoo Finance

a month ago

Why Scott Bessent wants to make it easier for banks to own Treasurys

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry

GlobeNewswire

a month ago

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry

GlobeNewswire

a month ago

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

PR Newswire

a month ago

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

Statement by Minister Guilbeault on Portuguese Heritage Month

CNW Group

a month ago

Statement by Minister Guilbeault on Portuguese Heritage Month

Man Utd sign Brazil forward Cunha from Wolves

AFP

a month ago

Man Utd sign Brazil forward Cunha from Wolves

‘All the crypto cowboys are gone’: Kevin O’Leary says the sector is safe now and is backing stablecoins

Moneywise

a month ago

‘All the crypto cowboys are gone’: Kevin O’Leary says the sector is safe now and is backing stablecoins

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference

GlobeNewswire

a month ago

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference

Why Cogent Biosciences (COGT) Is One of the Best Low Priced Biotech Stocks to Buy Now

Insider Monkey

2 months ago

Why Cogent Biosciences (COGT) Is One of the Best Low Priced Biotech Stocks to Buy Now

Cogent Biosciences Reports First Quarter 2025 Financial Results

GlobeNewswire

2 months ago

Cogent Biosciences Reports First Quarter 2025 Financial Results

Is Cogent Biosciences, Inc. (COGT) the Best Small Cap Stock to Buy with the Biggest Upside Potential?

Insider Monkey

2 months ago

Is Cogent Biosciences, Inc. (COGT) the Best Small Cap Stock to Buy with the Biggest Upside Potential?

Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders

GlobeNewswire

3 months ago

Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders

Cogent Biosciences (COGT): Among the Most Promising Penny Stocks According to Analysts

Insider Monkey

3 months ago

Cogent Biosciences (COGT): Among the Most Promising Penny Stocks According to Analysts

Is Cogent Biosciences Inc. (NASDAQ:COGT) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Insider Monkey

3 months ago

Is Cogent Biosciences Inc. (NASDAQ:COGT) the Best Biotech Penny Stock to Buy According to Hedge Funds?

We're Keeping An Eye On Cogent Biosciences' (NASDAQ:COGT) Cash Burn Rate

Simply Wall St.

3 months ago

We're Keeping An Eye On Cogent Biosciences' (NASDAQ:COGT) Cash Burn Rate

Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire

4 months ago

Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting

Cogent Biosciences Announces Participation in the Leerink Healthcare Conference

GlobeNewswire

4 months ago

Cogent Biosciences Announces Participation in the Leerink Healthcare Conference

Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients

GlobeNewswire

5 months ago

Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

5 months ago

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting

GlobeNewswire

5 months ago

Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting

Cogent Biosciences to Participate in the Guggenheim Biotech Conference

GlobeNewswire

5 months ago

Cogent Biosciences to Participate in the Guggenheim Biotech Conference

This Cogent Biosciences Insider Increased Their Holding By 2,085% Last Year

Simply Wall St.

6 months ago

This Cogent Biosciences Insider Increased Their Holding By 2,085% Last Year

Cole Pinnow Bought 2,085% More Shares In Cogent Biosciences

Simply Wall St.

6 months ago

Cole Pinnow Bought 2,085% More Shares In Cogent Biosciences

Argus Research

6 months ago

Daily – Vickers Top Buyers & Sellers for 01/16/2025

Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics

GlobeNewswire

6 months ago

Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics

Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

6 months ago

Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

Cogent Biosciences Announces Updated Clinical Results from SUMMIT, Showcasing Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients

GlobeNewswire

7 months ago

Cogent Biosciences Announces Updated Clinical Results from SUMMIT, Showcasing Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients

Cogent Biosciences Announces Positive Updated Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)

GlobeNewswire

7 months ago

Cogent Biosciences Announces Positive Updated Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)

Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting

GlobeNewswire

8 months ago

Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting

Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics

GlobeNewswire

9 months ago

Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics

Here's Why We're Not Too Worried About Cogent Biosciences' (NASDAQ:COGT) Cash Burn Situation

Simply Wall St.

9 months ago

Here's Why We're Not Too Worried About Cogent Biosciences' (NASDAQ:COGT) Cash Burn Situation

Analysts Rate Cogent Biosciences, Inc. (COGT) as Moderate Buy with $15 Target

Insider Monkey

9 months ago

Analysts Rate Cogent Biosciences, Inc. (COGT) as Moderate Buy with $15 Target

Cogent Biosciences Announces Phase 3 PEAK Trial in Patients with Gastrointestinal Stromal Tumors (GIST) Has Completed Enrollment and Advanced Past Interim Futility Analysis

GlobeNewswire

10 months ago

Cogent Biosciences Announces Phase 3 PEAK Trial in Patients with Gastrointestinal Stromal Tumors (GIST) Has Completed Enrollment and Advanced Past Interim Futility Analysis

Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results

GlobeNewswire

a year ago

Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results

Cogent Biosciences Announces Positive FDA Meeting and Alignment on MS2D2, a Novel Patient Reported Outcome Measure for the SUMMIT trial

GlobeNewswire

a year ago

Cogent Biosciences Announces Positive FDA Meeting and Alignment on MS2D2, a Novel Patient Reported Outcome Measure for the SUMMIT trial

Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evaluating Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)

GlobeNewswire

a year ago

Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evaluating Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)

Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer

GlobeNewswire

a year ago

Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer

Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting

GlobeNewswire

a year ago

Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting

We Think Cogent Biosciences (NASDAQ:COGT) Can Afford To Drive Business Growth

Simply Wall St.

a year ago

We Think Cogent Biosciences (NASDAQ:COGT) Can Afford To Drive Business Growth

Cogent Biosciences Reports First Quarter 2024 Financial Results

GlobeNewswire

a year ago

Cogent Biosciences Reports First Quarter 2024 Financial Results

Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor

GlobeNewswire

a year ago

Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor

GuruFocus.com

a year ago

COGT Reports Full Year 2023 Financial Results and Business Highlights

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

a year ago

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis

GlobeNewswire

a year ago

Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis

Cogent Biosciences Announces Oversubscribed $225 Million Private Placement

GlobeNewswire

a year ago

Cogent Biosciences Announces Oversubscribed $225 Million Private Placement

Cogent Biosciences to Present SUMMIT Part 1b Data with Bezuclastinib in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2024 AAAAI Annual Meeting

GlobeNewswire

a year ago

Cogent Biosciences to Present SUMMIT Part 1b Data with Bezuclastinib in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2024 AAAAI Annual Meeting

Gladstone Capital Corporation Earnings Call and Webcast Information

ACCESSWIRE

a year ago

Gladstone Capital Corporation Earnings Call and Webcast Information

This Vishay Precision Group Insider Increased Their Holding In The Last Year

Simply Wall St.

a year ago

This Vishay Precision Group Insider Increased Their Holding In The Last Year

STERIS (STE) Set to Post Q3 Earnings: What's in the Cards?

Zacks

a year ago

STERIS (STE) Set to Post Q3 Earnings: What's in the Cards?

Avid Bioservices (CDMO) Declined in 2023

Insider Monkey

a year ago

Avid Bioservices (CDMO) Declined in 2023

Invesco High Income Trust II, and Invesco Senior Income Trust Declare Dividends

PR Newswire

a year ago

Invesco High Income Trust II, and Invesco Senior Income Trust Declare Dividends

Thomson Reuters StreetEvents

a year ago

Q4 2023 CVRx Inc Earnings Call

CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates

Zacks

a year ago

CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates

Editas Medicine (NASDAQ:EDIT) shareholders have endured a 87% loss from investing in the stock three years ago

Simply Wall St.

a year ago

Editas Medicine (NASDAQ:EDIT) shareholders have endured a 87% loss from investing in the stock three years ago

NBT Bancorp Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

a year ago

NBT Bancorp Full Year 2023 Earnings: Misses Expectations

Beverages and Alcohol Stocks Q3 Highlights: Monster (NASDAQ:MNST)

StockStory

a year ago

Beverages and Alcohol Stocks Q3 Highlights: Monster (NASDAQ:MNST)

The 7 Most Undervalued Sleeper Stocks to Buy in January

InvestorPlace

a year ago

The 7 Most Undervalued Sleeper Stocks to Buy in January

American Superconductor (AMSC) Surges 5.4%: Is This an Indication of Further Gains?

Zacks

a year ago

American Superconductor (AMSC) Surges 5.4%: Is This an Indication of Further Gains?

Invesco Mortgage Capital (IVR) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Zacks

a year ago

Invesco Mortgage Capital (IVR) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Invesco Municipal Opportunity Trust's Dividend Analysis

GuruFocus.com

a year ago

Invesco Municipal Opportunity Trust's Dividend Analysis

While insiders own 36% of EHang Holdings Limited (NASDAQ:EH), individual investors are its largest shareholders with 46% ownership

Simply Wall St.

2 years ago

While insiders own 36% of EHang Holdings Limited (NASDAQ:EH), individual investors are its largest shareholders with 46% ownership

Insider Stock Buying Reaches US$527.5k On Avid Bioservices

Simply Wall St.

2 years ago

Insider Stock Buying Reaches US$527.5k On Avid Bioservices

Chatham Lodging Trust Announces Sale of Hotel

Business Wire

2 years ago

Chatham Lodging Trust Announces Sale of Hotel

Cogent Biosciences Announces Planned 2024 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics

GlobeNewswire

2 years ago

Cogent Biosciences Announces Planned 2024 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics

Shoe Carnival Inc's Dividend Analysis

GuruFocus.com

2 years ago

Shoe Carnival Inc's Dividend Analysis

Energy Recovery Inc CFO Joshua Ballard Sells 12,500 Shares

GuruFocus.com

2 years ago

Energy Recovery Inc CFO Joshua Ballard Sells 12,500 Shares

Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

GlobeNewswire

2 years ago

Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

Here's Why Investors Should Retain STERIS (STE) Stock for Now

Zacks

2 years ago

Here's Why Investors Should Retain STERIS (STE) Stock for Now

Standex International (NYSE:SXI) Might Have The Makings Of A Multi-Bagger

Simply Wall St.

2 years ago

Standex International (NYSE:SXI) Might Have The Makings Of A Multi-Bagger

Cogent Biosciences Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

2 years ago

Cogent Biosciences Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference

Companies Like Aerovate Therapeutics (NASDAQ:AVTE) Are In A Position To Invest In Growth

Simply Wall St.

2 years ago

Companies Like Aerovate Therapeutics (NASDAQ:AVTE) Are In A Position To Invest In Growth

Investing in CNB Financial (NASDAQ:CCNE) three years ago would have delivered you a 22% gain

Simply Wall St.

2 years ago

Investing in CNB Financial (NASDAQ:CCNE) three years ago would have delivered you a 22% gain

Diversified Healthcare Trust Closes $941 Million Zero Coupon Senior Secured Notes with a Maturity Date in January 2026, and a One-Year Extension Option

Business Wire

2 years ago

Diversified Healthcare Trust Closes $941 Million Zero Coupon Senior Secured Notes with a Maturity Date in January 2026, and a One-Year Extension Option

enCore Energy Transfers to NASDAQ; Continues to Trade Under "EU" Ticker Symbol

PR Newswire

2 years ago

enCore Energy Transfers to NASDAQ; Continues to Trade Under "EU" Ticker Symbol

Diversified Healthcare Trust Prices $941 Million Zero Coupon Senior Secured Notes with a Maturity Date of January 15, 2026 and a One-Year Extension Option

Business Wire

2 years ago

Diversified Healthcare Trust Prices $941 Million Zero Coupon Senior Secured Notes with a Maturity Date of January 15, 2026 and a One-Year Extension Option

Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc

GuruFocus.com

2 years ago

Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc

Here’s Why Newpark Resources (NR) Rose in Q3

Insider Monkey

2 years ago

Here’s Why Newpark Resources (NR) Rose in Q3

Insider Sell Alert: President and CEO Russell Diez-Canseco Sells 26,069 Shares of Vital Farms ...

GuruFocus.com

2 years ago

Insider Sell Alert: President and CEO Russell Diez-Canseco Sells 26,069 Shares of Vital Farms ...

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Quanex Building Products Corp Earnings Call

Vital Farms’ New Pause Ad Activation Celebrates Those Who Don’t Get to Pause, Even During Holidays: Farmers

GlobeNewswire

2 years ago

Vital Farms’ New Pause Ad Activation Celebrates Those Who Don’t Get to Pause, Even During Holidays: Farmers

MicroVision Reiterates Revenue Guidance and Provides Updates on OEM Engagements

ACCESSWIRE

2 years ago

MicroVision Reiterates Revenue Guidance and Provides Updates on OEM Engagements

Vital Farms to Participate in January 2024 Investor Conferences

GlobeNewswire

2 years ago

Vital Farms to Participate in January 2024 Investor Conferences

Cogent Biosciences Announces Positive Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)

GlobeNewswire

2 years ago

Cogent Biosciences Announces Positive Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)

Newpark Resources, Inc. (NYSE:NR) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Simply Wall St.

2 years ago

Newpark Resources, Inc. (NYSE:NR) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Cogent Biosciences Announces Positive Initial Data from Phase 2 SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM)

GlobeNewswire

2 years ago

Cogent Biosciences Announces Positive Initial Data from Phase 2 SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM)

Avid Bioservices, Inc. (NASDAQ:CDMO) Q2 2024 Earnings Call Transcript

Insider Monkey

2 years ago

Avid Bioservices, Inc. (NASDAQ:CDMO) Q2 2024 Earnings Call Transcript

Does AnaptysBio, Inc. (ANAB) Have the Potential to Rally 69.36% as Wall Street Analysts Expect?

Zacks

2 years ago

Does AnaptysBio, Inc. (ANAB) Have the Potential to Rally 69.36% as Wall Street Analysts Expect?

Cogent Biosciences Presents New Preclinical Data Highlighting Potential Best-in-Class Potency and Selectivity of ErbB2 and PI3Kα inhibitor programs at the San Antonio Breast Cancer Symposium

GlobeNewswire

2 years ago

Cogent Biosciences Presents New Preclinical Data Highlighting Potential Best-in-Class Potency and Selectivity of ErbB2 and PI3Kα inhibitor programs at the San Antonio Breast Cancer Symposium

Chatham Lodging Trust Declares Quarterly Common, Preferred Dividend

Business Wire

2 years ago

Chatham Lodging Trust Declares Quarterly Common, Preferred Dividend

Remembering Charlie Munger

GuruFocus.com

2 years ago

Remembering Charlie Munger

Cogent Biosciences to Host Investor Webcast on December 11, 2023 at 8:00 AM ET to Review Clinical Data Being Presented at American Society of Hematology (ASH) Annual Meeting

GlobeNewswire

2 years ago

Cogent Biosciences to Host Investor Webcast on December 11, 2023 at 8:00 AM ET to Review Clinical Data Being Presented at American Society of Hematology (ASH) Annual Meeting

Douglas Dynamics (NYSE:PLOW) investors are sitting on a loss of 24% if they invested three years ago

Simply Wall St.

2 years ago

Douglas Dynamics (NYSE:PLOW) investors are sitting on a loss of 24% if they invested three years ago

Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer Symposium

GlobeNewswire

2 years ago

Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer Symposium

The past year for Magic Software Enterprises (NASDAQ:MGIC) investors has not been profitable

Simply Wall St.

2 years ago

The past year for Magic Software Enterprises (NASDAQ:MGIC) investors has not been profitable

New Research: 97% of U.S. CIOs Identify Cybersecurity as a Current Major Threat to Their Organization

Business Wire

2 years ago

New Research: 97% of U.S. CIOs Identify Cybersecurity as a Current Major Threat to Their Organization

Is Cogent Biosciences (NASDAQ:COGT) In A Good Position To Deliver On Growth Plans?

Simply Wall St.

2 years ago

Is Cogent Biosciences (NASDAQ:COGT) In A Good Position To Deliver On Growth Plans?

Don't Buy United Fire Group, Inc. (NASDAQ:UFCS) For Its Next Dividend Without Doing These Checks

Simply Wall St.

2 years ago

Don't Buy United Fire Group, Inc. (NASDAQ:UFCS) For Its Next Dividend Without Doing These Checks

United Fire Group (NASDAQ:UFCS) Is Due To Pay A Dividend Of $0.16

Simply Wall St.

2 years ago

United Fire Group (NASDAQ:UFCS) Is Due To Pay A Dividend Of $0.16

Share on Social Networks: